• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition

tetano

Editor, Senior Moderator
Sci Rep. 2016 Sep 15;6:33334. doi: 10.1038/srep33334.
[h=1]Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition.[/h] Woolthuis RG[SUP]1,[/SUP][SUP]2[/SUP], van Dorp CH[SUP]1,[/SUP][SUP]2[/SUP], Keşmir C[SUP]1[/SUP], de Boer RJ[SUP]1[/SUP], van Boven M[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] The evolutionary adaptation of the influenza A virus (IAV) to human antibodies is well characterised. Much less is known about the long-term evolution of cytotoxic T lymphocyte (CTL) epitopes, which are important antigens for clearance of infection. We construct an antigenic map of IAVs of all human subtypes using a compendium of 142 confirmed CTL epitopes, and show that IAV evolved gradually in the period 1932-2015, with infrequent antigenic jumps in the H3N2 subtype. Intriguingly, the number of CTL epitopes per virus decreases with more than one epitope per three years in the H3N2 subtype (from 84 epitopes per virus in 1968 to 64 in 2015), mostly attributed to the loss of HLA-B epitopes. We confirm these observations with epitope predictions. Our findings indicate that selection pressures imposed by CTL immunity shape the long-term evolution of IAV.


PMID: 27629812 DOI: 10.1038/srep33334
[PubMed - in process] Free full text
 
Back
Top Bottom